![Frontiers | Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance Frontiers | Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance](https://www.frontiersin.org/files/Articles/539974/fmed-07-00410-HTML/image_m/fmed-07-00410-t004.jpg)
Frontiers | Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance
![Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England | British Journal of Cancer Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-020-01221-9/MediaObjects/41416_2020_1221_Fig2_HTML.png)
Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England | British Journal of Cancer
![Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study | Gut Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study | Gut](https://gut.bmj.com/content/gutjnl/70/6/1130/F2.large.jpg)
Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study | Gut
![Frontiers | Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance Frontiers | Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance](https://www.frontiersin.org/files/Articles/539974/fmed-07-00410-HTML/image_m/fmed-07-00410-t007.jpg)
Frontiers | Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance
Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms | PLOS ONE
![Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening | Gut Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening | Gut](https://gut.bmj.com/content/gutjnl/62/5/727/F2.large.jpg)
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening | Gut
![Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening | Gut Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening | Gut](https://gut.bmj.com/content/gutjnl/62/5/727/F1.large.jpg)
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening | Gut
![Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England | British Journal of Cancer Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-020-01221-9/MediaObjects/41416_2020_1221_Fig4_HTML.png)